ArTara Therapeutics, Inc.

NEW YORK, NY · Founded 2017 · CIK 0001724697 · Biotech · Public

Investigational cell therapy (TARA-002) for treating disease

protaratx.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$4.2M
1 Form D · Jan 2018
105 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$4,150,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1456VIAMUNE, INC.——
1457Neuralexo, LLC——
1458MICROBITYPE LLC——
1459ArTara Therapeutics, Inc.—$4.2M
1460REVIVBIO, INC—$3.1M
1461Cage Bio, Inc.—$19M
1462PridCor Therapeutics, LLC—$6.0M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Randall MarshallDirector · Executive Officer
  • Jesse SheffermanDirector · Executive Officer
  • David SmithExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.